Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Format:	Artigo
Language:	English
Published:	2001
Online Access:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
by: Ryutaro Oba, et al.
Published: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
by: Zou, Kun, et al.
Published: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
by: Assarsson, Anna, et al.
Published: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
by: Anna Assarsson, et al.
Published: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
by: Yuji Yoshiike, et al.
Published: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
by: Kun Zou, et al.
Published: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
by: Wisniewski, Thomas, et al.
Published: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
by: Abelein, Axel, et al.
Published: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
by: Axel Abelein, et al.
Published: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
by: Joshi, P, et al.
Published: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
by: P. Joshi, et al.
Published: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
by: Zou, Kun, et al.
Published: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
by: Kun Zou, et al.
Published: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
by: Fan, Yujuan, et al.
Published: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
by: Elizabeth A. Eckman, et al.
Published: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
by: Kimberly Boland, et al.
Published: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
by: Davis, Stephani A., et al.
Published: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
by: Stephani A. Davis, et al.
Published: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
by: Korshavn, Kyle J., et al.
Published: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
by: Kyle J. Korshavn, et al.
Published: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
by: Garai, Kanchan, et al.
Published: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
by: Kanchan Garai, et al.
Published: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
by: Shuyu Liu, et al.
Published: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
by: Du, Wen-Jie, et al.
Published: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
by: Wenjie Du, et al.
Published: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
by: Mikhail Matveyenka, et al.
Published: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
by: Wang, Qiuming, et al.
Published: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
by: Qiuming Wang, et al.
Published: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
by: Hemming, Matthew L., et al.
Published: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
by: Larmuth, Kate M., et al.
Published: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
by: Matthew L. Hemming, et al.
Published: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
by: Hou, Li‐Na, et al.
Published: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
by: Jin, Sha, et al.
Published: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
by: Sha Jin, et al.
Published: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
by: Srivastava, Atul K., et al.
Published: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
by: Atul Srivastava, et al.
Published: (2019)

Aggregation and structure of amyloid β-protein
by: Kenjiro Ono, et al.
Published: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
by: Takami Tomiyama, et al.
Published: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
by: Wang, Peng, et al.
Published: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
by: Kehoe, Patrick Gavin, et al.
Published: (2016)